aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.8363
+0.0117 (1.42%)
At close: Oct 7, 2025, 4:00 PM EDT
0.8400
+0.0037 (0.44%)
After-hours: Oct 7, 2025, 4:38 PM EDT
aTyr Pharma Stock Forecast
ATYR's stock price has decreased by -54.81% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts that cover aTyr Pharma stock have a consensus rating of "Buy" and an average price target of $8.88, which forecasts a 961.82% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $17.
Price Target: $8.88 (+961.82%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for aTyr Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 4 | 4 | 4 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $25 → $1 | Buy → Hold | Downgrades | $25 → $1 | +19.57% | Sep 16, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $16 → $1.5 | Buy → Hold | Downgrades | $16 → $1.5 | +79.36% | Sep 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 15, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $9 → $17 | Strong Buy | Maintains | $9 → $17 | +1,932.76% | Aug 22, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $25 | Buy | Maintains | $17 → $25 | +2,889.36% | Jun 20, 2025 |
Financial Forecast
Revenue This Year
1.22M
from 235.00K
Increased by 420.85%
Revenue Next Year
24.72M
from 1.22M
Increased by 1,919.44%
EPS This Year
-0.75
from -0.86
EPS Next Year
-0.66
from -0.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.6M | 123.9M | |||
| Avg | 1.2M | 24.7M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5,261.7% | 10,022.5% | |||
| Avg | 420.9% | 1,919.4% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.62 | -0.23 | |||
| Avg | -0.75 | -0.66 | |||
| Low | -0.83 | -1.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.